NasdaqGM - Delayed Quote
USD
Braveheart Bio, Inc. (BRVE)
18.60
+1.19
(+6.80%)
At close: November 6 at 4:00:01 PM EST
Earnings Trends
Earnings Per Share (GAAP)
Revenue vs. Earnings
Q2 FY26
Revenue
--
Earnings
-18.6M
Profit Margin
0.00%
Q2
FY26
-15M
-10M
-5M
0
0.0%
Revenue Estimate
| Currency in USD
|
Current Qtr. (Sep 2026)
|
Next Qtr. (Dec 2026)
|
Current Year (2026)
|
Next Year (2027)
|
|---|---|---|---|---|
|
No. of Analysts
|
5 | 5 | 5 | 5 |
|
Avg. Estimate
|
-- | -- | -- | -- |
|
Low Estimate
|
-- | -- | -- | -- |
|
High Estimate
|
-- | -- | -- | -- |
|
Year Ago Sales
|
-- | -- | -- | -- |
|
Sales Growth (year/est)
|
-- | -- | -- | 0.00% |
Earnings Estimate
| Currency in USD
|
Current Qtr. (Sep 2026)
|
Next Qtr. (Dec 2026)
|
Current Year (2026)
|
Next Year (2027)
|
|---|---|---|---|---|
|
No. of Analysts
|
-- | -- | -- | -- |
|
Avg. Estimate
|
-- | -- | -- | -- |
|
Low Estimate
|
-- | -- | -- | -- |
|
High Estimate
|
-- | -- | -- | -- |
|
Year Ago EPS
|
-- | -- | -- | -- |
Earnings History
EPS Trend
| Currency in USD
|
Current Qtr. (Sep 2026)
|
Next Qtr. (Dec 2026)
|
Current Year (2026)
|
Next Year (2027)
|
|---|---|---|---|---|
|
Current Estimate
|
-- | -- | -- | -- |
|
7 Days Ago
|
-- | -- | -- | -- |
|
30 Days Ago
|
-- | -- | -- | -- |
|
60 Days Ago
|
-- | -- | -- | -- |
|
90 Days Ago
|
-- | -- | -- | -- |
EPS Revisions
| Currency in USD
|
Current Qtr. (Sep 2026)
|
Next Qtr. (Dec 2026)
|
Current Year (2026)
|
Next Year (2027)
|
|---|---|---|---|---|
|
Up Last 7 Days
|
-- | -- | -- | -- |
|
Up Last 30 Days
|
-- | -- | -- | -- |
|
Down Last 7 Days
|
-- | -- | -- | -- |
|
Down Last 30 Days
|
-- | -- | -- | -- |
Growth Estimates
| Symbol | Current Qtr. | Next Qtr. | Current Year | Next Year |
|---|---|---|---|---|
|
BRVE
|
-- | -- | -- | -- |
|
S&P 500
|
28.67% | 27.50% | 33.36% | 16.57% |
